Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
NVIDIA
NVDA
|
$1.23B |
| 2 |
Salesforce
CRM
|
$777M |
| 3 |
Flutter Entertainment
FLUT
|
$622M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$569M |
| 5 |
Amazon
AMZN
|
$566M |
Top Sells
| 1 |
Broadcom
AVGO
|
$1.95B |
| 2 |
MRO
Marathon Oil Corporation
MRO
|
$738M |
| 3 |
Alibaba
BABA
|
$328M |
| 4 |
Vistra
VST
|
$313M |
| 5 |
Wells Fargo
WFC
|
$265M |
Sector Composition
| 1 | Technology | 25.45% |
| 2 | Financials | 12.86% |
| 3 | Industrials | 11.54% |
| 4 | Consumer Discretionary | 10.57% |
| 5 | Healthcare | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3626
Ovid Therapeutics
OVID
$94.6M
| $25.4K | ﹤0.01% |
27,207
-2,130
| -7% | -$1.99K |
|
3627
FibroBiologics
FBLG
$25.3M
| $25.3K | ﹤0.01% |
12,659
+240
| +2% | +$480 |
|
3628
Traeger
COOK
$170M
| $24.4K | ﹤0.01% |
+10,202
| New | +$24.4K |
|
3629
Renovaro
RENB
$51.4M
| $24.3K | ﹤0.01% |
29,067
+6,240
| +27% | +$5.21K |
|
3630
Shattuck Labs
STTK
$61.3M
| $22.7K | ﹤0.01% |
18,726
+337
| +2% | +$408 |
|
3631
Inovio Pharmaceuticals
INO
$144M
| $22K | ﹤0.01% |
12,037
+1,024
| +9% | +$1.87K |
|
3632
Werewolf Therapeutics
HOWL
$62.6M
| $21.6K | ﹤0.01% |
14,589
+953
| +7% | +$1.41K |
|
|
EQC
3633
DELISTED
Equity Commonwealth
EQC
| $19.2K | ﹤0.01% |
10,870
-229,094
| -95% | -$405K |
|
3634
Tenaya Therapeutics
TNYA
$192M
| $18.4K | ﹤0.01% |
12,876
+1,704
| +15% | +$2.44K |
|
3635
374Water
SCWO
$49.9M
| $18.4K | ﹤0.01% |
26,971
+563
| +2% | +$384 |
|
3636
RAPT Therapeutics
RAPT
$187M
| $18.2K | ﹤0.01% |
1,439
-16
| -1% | -$202 |
|
3637
Tevogen Bio Holdings
TVGN
$175M
| $17.5K | ﹤0.01% |
17,023
+6,862
| +68% | +$7.07K |
|
3638
Invivyd
IVVD
$218M
| $16.6K | ﹤0.01% |
37,514
+3,124
| +9% | +$1.38K |
|
|
NKLA
3639
DELISTED
Nikola Corporation Common Stock
NKLA
| $16.4K | ﹤0.01% |
13,818
-1,221
| -8% | -$1.45K |
|
3640
Actinium Pharmaceuticals
ATNM
$53.3M
| $15.7K | ﹤0.01% |
12,425
+259
| +2% | +$326 |
|
3641
Generation Bio
GBIO
$40.3M
| $15.2K | ﹤0.01% |
1,436
+195
| +16% | +$2.07K |
|
|
ELEV
3642
DELISTED
Elevation Oncology
ELEV
| $13.9K | ﹤0.01% |
24,795
+449
| +2% | +$253 |
|
3643
Gores Guggenheim
PSNY
$2.33B
| $12.8K | ﹤0.01% |
+12,219
| New | +$12.8K |
|
3644
System1
SST
$57.2M
| $10K | ﹤0.01% |
1,117
+20
| +2% | +$180 |
|
|
AMRN
3645
Amarin Corp
AMRN
$311M
| $8.13K | ﹤0.01% |
838
-3,439
| -80% | -$33.4K |
|
3646
Scilex Holding
SCLX
$131M
| $8.03K | ﹤0.01% |
538
| – | – |
|
3647
MarketWise
MKTW
$48.6M
| $7.71K | ﹤0.01% |
679
+20
| +3% | +$227 |
|
3648
Lyra Therapeutics
LYRA
$11.8M
| $4.88K | ﹤0.01% |
473
+20
| +4% | +$206 |
|
3649
CDT Equity Inc. Common Stock
CDT
$3.66M
| $883 | ﹤0.01% |
9
+2
| +29% | +$196 |
|
3650
AC Immune
ACIU
$227M
| – | – |
-17,362
| Closed | -$65.6K |
|